Author

Laura M. Millett

Cancer Research UK Scotland InstituteORCID 0009-0000-7596-4275Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

Andrew D. CampbelliD· 2 shared Arafath Kaja NajumudeeniD· 2 shared Catriona A. FordiD· 2 shared Colin NixoniD· 2 shared Jennifer P. MortoniD· 2 shared Kathryn L. GilroyiD· 2 shared Owen James SansomiD· 2 shared Sigrid K. FeyiD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andrew D. CampbellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedOct 16, 2024

Kras loss of heterozygosity promotes MAPK dependent pancreatic ductal adenocarcinoma and induces therapeutic sensitivity

Sigrid K. Fey, Arafath Kaja Najumudeen, Dale M. Watt…·Owen James Sansom

This study shows that loss of wild-type Kras enhances oncogenic Kras signaling and promotes pancreatic ductal adenocarcinoma, while also increasing sensitivity to MEK1/2 inhibitors.

12 citations

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedJan 2, 2024

KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo

Arafath Kaja Najumudeen, Sigrid K. Fey, Laura M. Millett…·Owen James Sansom

This study shows that wild-type KRAS suppresses tumour growth and metastasis in KRAS mutant colorectal cancer while enhancing resistance to MEK inhibition.

27 citations

mouseexperimental assay

𝕏 PostBluesky